ThTP7.1 An audit of outcome of rectal cancer patients who were offered primary surgery. Are we following NICE guidelines for management of rectal cancer? –A retrospective cross sectional study at a District General Hospital

Abstract

Abstract Aims The aim of this audit was to analyse whether we are following NICE guidelines regarding management of the rectal cancer. We also analysed the outcome of rectal cancer patients who were offered primary surgery. Methods It was a retrospective study in design. We evaluated 47 patients out of 266 patients who were registered as rectal cancer between 2017 to 2022. Only patients who were offered primary surgery were included. Patients with metastatic cancer, those unfit for chemoradiotherapy and those who were offered neoadjuvant therapy were excluded. Results We identified 47 patients with rectal cancer for evaluation. The mean age at presentation was 72 years. 65.95% (n=31/47) were men, 34.05 % (n=16/47) were women. After a median follow of 34 months, local recurrence rate was noted in 24% and distant metastasis in 32%. We also noted that 52% of the patients were disease free and total mortality of 12%. Conclusion Preoperative chemoradiotherapy comprises a vital part of the management part for rectal cancer patients. Evidence has showed that it decreases the local recurrence rate and increases the overall disease free survival. In our study, we found that compliance to the NICE guidelines was not satisfactory and outcome results were not at par with National Cancer Excellence centre's of the United Kingdom. The recommendation was to follow the updated NICE guidelines in order to standardize the treatment throughout the United Kingdom and for better outcome results.